<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Hack, C.E.</title>
    <link>http://repub.eur.nl/res/aut/2274/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C (Article)</title>
      <link>http://repub.eur.nl/res/pub/38493/</link>
      <pubDate>2012-12-01T00:00:00Z</pubDate>
      <description>Objective:: Cell death leading to circulating nucleosomes and histones is a critical step in the pathogenesis of sepsis and contributes to lethality. Activated protein C was demonstrated to attenuate the harmful effects of histones. The Objective of this retrospective study was to evaluate whether nucleosomes correlate with the severity of the inflammatory response and mortality in children suffering from severe meningococcal sepsis. Furthermore, we wanted to study the effects of infusion of protein C on nucleosome levels in children with septic purpura. DESIGN:: Retrospective analysis of nucleosome levels in children suffering from meningococcal sepsis treated with either placebo or protein C. SETTING:: Pediatric intensive care unit of a tertiary care university center. PATIENTS:: In a randomized, placebo-controlled study, either protein C or placebo was administered to 38 children suffering from meningococcal sepsis. Nucleosome levels have been measured retrospectively in these 38 children suffering from meningococcal sepsis. MEASUREMENTS AND MAIN Results:: Twenty-eight children were treated with protein C and 10 received placebo. Nucleosome levels were significantly higher in nonsurvivors (n = 9) at any time point measured as compared to survivors (n = 29). Nucleosome levels significantly correlated with organ dysfunction scores, cytokines, and parameters for coagulation. Patients treated with protein C had significantly higher activated protein C levels than children receiving placebo. We could not find a clear effect of activated protein C on nucleosome levels in these patients. CONCLUSION:: Circulating nucleosomes correlated with the severity of the inflammatory response and were associated with mortality in children suffering from meningococcal sepsis. We show that protein C administration does not decrease nucleosome levels in these patients. </description>
    </item> <item>
      <title>Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity (Article)</title>
      <link>http://repub.eur.nl/res/pub/3908/</link>
      <pubDate>2003-05-01T00:00:00Z</pubDate>
      <description>The kinetics of total and dengue virus-specific immunoglobulin E (IgE) were studied in serial serum samples obtained from 168 patients, 41 of whom suffered from primary dengue virus infection and 127 suffered from secondary dengue virus infection. Seventy-one patients were classified as dengue fever, 30 as dengue hemorrhagic fever, and 67 as dengue shock syndrome. A control group included single serum samples from patients with a herpes virus infection (n = 14), non-dengue febrile patients (n = 10), and healthy blood donors (n = 10). Patients with dengue virus infection had higher levels of total and dengue virus-specific IgE than non-dengue patients (P &lt; 0.05). Patients with secondary dengue virus infections had not significantly increased levels of both total and dengue virus-specific IgE in the acute phase of disease compared to patients with primary dengue virus infections. Dengue virus-specific IgE was significantly higher in dengue hemorrhagic fever and/or dengue shock syndrome patients compared to dengue fever and non-dengue patients (P &lt; 0.05). In conclusion, this study showed elevated total and dengue virus-specific IgE serum antibody levels in the acute stage of disease. Therefore, measurement of both total and dengue virus-specific IgE serum antibodies can be used as an additional prognostic marker in the development of severe complications in dengue virus infections. In addition, the presence and increase of dengue virus-specific IgE serum antibodies in patients with dengue virus infections is suggestive of the pathogenetic role that IgE may play in the hemostatic disorders observed in dengue hemorrhagic fever and dengue shock syndrome.</description>
    </item> <item>
      <title>Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12998/</link>
      <pubDate>2001-12-17T00:00:00Z</pubDate>
      <description>The kinetics of dengue virus (DEN)-specific serum immunoglobulin classes (immunoglobulin M [IgM] and IgA) and subclasses (IgG1 to IgG4) were studied in patients suffering from dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). Serum samples from non-DEN febrile patients were included as controls. IgM, IgG1, and IgG3 serum antibodies were the predominant immunoglobulins throughout the course of illness in all three patient groups. In contrast, IgA antibodies were significantly higher in the acute phase in DSS patients compared to those in DF patients (P &lt; 0.05). The levels of IgG1 differed significantly between patients with DF and those with DHF and DSS (P &lt; 0.05). A significant difference was also found in IgG3 levels between DF patients and DHF patients (P &lt; 0.05) but not between DF patients and DSS patients. Finally, levels of IgG4 antibodies differed significantly between DF patients and DSS patients (P &lt; 0.05). Collectively, these data show that increased levels of DEN-specific IgA, IgG1, and IgG4 serum antibodies are risk markers for the development of DHF and DSS and that their measurement may provide valuable guidance for early therapeutic intervention.
AD  - Laboratory for Exotic Viral Infections, Institute of Virology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.</description>
    </item> <item>
      <title>Complement activation in relation to capillary leakage in children with septic shock and purpura (Article)</title>
      <link>http://repub.eur.nl/res/pub/8919/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>To assess the relationship between capillary leakage and inflammatory
          mediators during sepsis, blood samples were taken on hospital admission,
          as well as 24 and 72 h later, from 52 children (median age, 3.3 years)
          with severe meningococcal sepsis, of whom 38 survived and 14 died.
          Parameters related to cytokines (interleukin 6 [IL-6] IL-8, plasma
          phospholipase A2, and C-reactive protein [CRP]), to neutrophil
          degranulation (elastase and lactoferrin), to complement activation (C3a,
          C3b/c, C4b/c, and C3- and C4-CRP complexes), and to complement regulation
          (functional and inactivated C1 inhibitor and C4BP) were determined. The
          degree of capillary leakage was derived from the amount of plasma infused
          and the severity of disease by assessing the pediatric risk of mortality
          (PRISM) score. Levels of IL-6, IL-8, C3b/c, C3-CRP complexes, and C4BP on
          admission, adjusted for the duration of skin lesions, were significantly
          different in survivors and nonsurvivors (C3b/c levels were on average 2.2
          times higher in nonsurvivors, and C3-CRP levels were 1.9 times higher in
          survivors). Mortality was independently related to the levels of C3b/c and
          C3-CRP complexes. In agreement with this, levels of complement activation
          products correlated well with the PRISM score or capillary leakage. Thus,
          these data show that complement activation in patients with severe
          meningococcal sepsis is associated with a poor outcome and a more severe
          disease course. Further studies should reveal whether complement
          activation may be a target for therapeutical intervention in this disease.</description>
    </item> <item>
      <title>Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis (Article)</title>
      <link>http://repub.eur.nl/res/pub/8651/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>To assess the role of interleukin-12 (IL-12) and gamma interferon
          (IFN-gamma) in children with bacterial meningitis, bioactive IL-12 (p70)
          and the inactive subunit p40 and IFN-gamma were measured in serum and
          cerebrospinal fluid (CSF) from 35 children with bacterial meningitis and
          10 control subjects. The production of IFN-gamma is induced by IL-12 with
          tumor necrosis factor alpha (TNF-alpha) as a costimulator and inhibited by
          IL-10. CSF concentrations of IL-12 p40 as well as those of IFN-gamma were
          markedly elevated, whereas IL-12 p70 was hardly detectable. Detectable CSF
          levels of IFN-gamma correlated positively with IL-12 p40 (r = 0.40, P =
          0.02) and TNF-alpha (r = 0.46, P = 0.04) but not with IL-6, IL-8, or
          IL-10. In contrast to CSF levels of TNF-alpha, IL-12, and IL-10, those of
          IFN-gamma were significantly higher in patients with pneumococcal
          meningitis than in children with meningitis caused by Haemophilus
          influenzae and Neisseria meningitidis, presumably because of a high CSF
          TNF-alpha/IL-10 ratio in the former. We suggest that IL-12- and
          TNF-alpha-induced IFN-gamma production may contribute to the natural
          immunity against microorganisms in the CSF compartment during the acute
          phase of bacterial meningitis.</description>
    </item>
  </channel>
</rss>